1-3 of 3
Sangeeta Aggarwal, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Voice of Cancer Patients: Patient Experience Regarding Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Sangeeta Aggarwal, MD, Singh Manish, B.Tech, Guroosh Chaudhary, Alok Aggarwal, PhD, Himanshu Punetha, M. Tech, Juhi Jha, Rahul Kumar Gond
Journal: Blood
Blood (2019) 134 (Supplement_1): 5843.
https://doi.org/10.1182/blood-2019-125195
Published: 2019
Journal Articles

Voice of Cancer Patients (VoCP): Analysis of Patient Experiences and Use of Burton's Tyrosine Kinase (BTK) Inhibitors and Venetoclax in Hematological Malignancies

Sangeeta Aggarwal, MD, Alok Aggarwal, PhD, Jyoti Bhowmick, M.B.A., Rishi Sharma, B.Tech, Rahul Gond, Siddhant Kapoor, B.Tech, Sujeet Kumar, B.Tech
Journal: Blood
Blood (2018) 132 (Supplement 1): 3582.
https://doi.org/10.1182/blood-2018-99-119727
Published: 2018
Journal Articles

Multicenter Phase II Trial of the Histone Deacetylase Inhibitor Depsipeptide (FK228) for the Treatment of Relapsed or Refractory Multiple Myeloma (MM).

Ruben Niesvizky, MD, Scott Ely, MD, MPH, Maurizio DiLiberto, PhD, Hearn J. Cho, MD, PhD, Udi Y. Gelbshtein, David S. Jayabalan, Sangeeta Aggarwal, MD, Janice L. Gabrilove, MD, Roger N. Pearse, MD, PhD, Karen Pekle, RN, ANPC, Faiza Zafar, RPAC, Zoe Goldberg, MD, John P. Leonard, MD, John J. Wright, MD, Selina Chen-Kiang, PhD, Morton Coleman, MD
Journal: Blood
Blood (2005) 106 (11): 2574.
https://doi.org/10.1182/blood.V106.11.2574.2574
Published: 2005